Related Experiment Videos
[Experience in heptral treatment of diffuse liver diseases]
Aim:
Heptral trial in alcoholic, drug and viral diseases of the liver.
Materials And Methods:
67 patients with chronic diffuse liver diseases were treated with heptral. The examination covered AlAt, AP, HHTP, bilirubin, cholesterol, CT of the liver, esophagogastroduodenoscopy. Heptral was given by two steps: 14 days of intravenous drops (800 mg/day) followed by 14 days of oral use (2 tablets, 400 mg each) before meal at 8 a.m. and 2 p.m.
Results:
In alcoholic disease of the liver, heptral relieved depression, reduced AlAT, AP, HHTP, bilirubin, density of the liver. The addition of heptral to interferon-alpha-2 treatment of chronic hepatitis C corrected intrahepatic cholestasis. In drug-induced liver damage heptral promoted normalization of the hepatic tests, improved general condition of the patients.
Conclusion:
Heptral is effective in patients with alcoholic and drug liver lesions, chronic hepatitis C.